These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11449689)

  • 1. [The sub-classification and long-term prognosis of preproliferative diabetic retinopathy].
    Sato Y; Lee Z
    Nippon Ganka Gakkai Zasshi; 2001 Jun; 105(6):394-8. PubMed ID: 11449689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subclassification and long-term prognosis of preproliferative diabetic retinopathy.
    Sato Y; Lee Z
    Jpn J Ophthalmol; 2002; 46(3):323-9. PubMed ID: 12063044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preproliferative diabetic retinopathy sub-classification and glycemic control--relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy].
    Sato Y; Lee Z; Hayashi Y
    Nippon Ganka Gakkai Zasshi; 2001 May; 105(5):322-5. PubMed ID: 11406948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photopic electroretinogram implicit time in diabetic retinopathy.
    Satoh S; Iijima H; Imai M; Abe K; Shibuya T
    Jpn J Ophthalmol; 1994; 38(2):178-84. PubMed ID: 7967210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclassification of preproliferative diabetic retinopathy and glycemic control: relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy.
    Sato Y; Lee Z; Hayashi Y
    Jpn J Ophthalmol; 2001; 45(5):523-7. PubMed ID: 11583677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclassification of preproliferative diabetic retinopathy.
    Sato Y; Kamata A; Matsui M
    Jpn J Ophthalmol; 1993; 37(4):490-8. PubMed ID: 8145395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and classification of proliferative diabetic vitreoretinopathy.
    Kroll P; Rodrigues EB; Hoerle S
    Ophthalmologica; 2007; 221(2):78-94. PubMed ID: 17380062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The sub-classification of pre-proliferative diabetic retinopathy].
    Sato Y; Kamata A; Matsui M
    Nippon Ganka Gakkai Zasshi; 1993 Feb; 97(2):247-52. PubMed ID: 8475838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal outcomes in proliferative diabetic retinopathy presenting during and after pregnancy.
    Chen YJ; Kuo HK; Huang HW
    Chang Gung Med J; 2004 Sep; 27(9):678-84. PubMed ID: 15605908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal light scattering detected by confocal biomicroscopy at the corneal epithelial basement membrane of subjects with type II diabetes.
    Morishige N; Chikama TI; Sassa Y; Nishida T
    Diabetologia; 2001 Mar; 44(3):340-5. PubMed ID: 11317666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proliferative retinopathy--pathogenesis and classification from the aspect if indications for laser photocoagulation, and its incidence in materials of the Eye Clinic in Wroclaw].
    Nizankowska MH; Lukasik-Czerek A; Oficjalska-Młyńczak J
    Klin Oczna; 1995; 97(9-10):276-8. PubMed ID: 8833948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
    JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effect of argon green laser for diabetic retinopathy].
    Tang LP; Feng HY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1452-4. PubMed ID: 15604086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
    Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
    Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous.
    Dai Y; Wu Z; Wang F; Zhang Z; Yu M
    Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.